Hannah Alison L

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Hannah Alison L
CIK #0001645600
EDGAR Form CIK 2011 - 2026
3 [0001645600]
4 [0001645600]
Form 3/4/5 Subject 2011 - 2026
Hannah Alison L
Rigel Pharmaceuticals Inc
Neogenomics Inc
CytomX Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Neogenomics Inc NEO
Stock Option (Right to Buy) · derivative
2025-06-01 Grant 16,107 $0.00
Neogenomics Inc NEO
Common Stock
2025-06-01 Grant 12,254 $0.00
Neogenomics Inc NEO
Restricted Stock Unit · derivative
2025-06-01 Option exercise 12,254 $0.00
Neogenomics Inc NEO
Restricted Stock Unit · derivative
2025-06-01 Grant 23,077 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2025-05-23 Grant 2,500 $0.00
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
2025-05-23 Grant 3,000 $0.00
Neogenomics Inc NEO
Common Stock
2024-08-10 Option exercise 11,336 $0.00
Neogenomics Inc NEO
Restricted Stock Unit · derivative
2024-08-10 Option exercise 11,336 $0.00
Neogenomics Inc NEO
Restricted Stock Unit · derivative
2024-06-01 Grant 12,254 $0.00
Neogenomics Inc NEO
Stock Option (Right to Buy) · derivative
2024-06-01 Grant 8,672 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2024-05-25 Grant 25,000 $0.00
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
2024-05-25 Grant 30,000 $0.00
Neogenomics Inc NEO
Stock Option (Right to Buy) · derivative
2023-08-10 Grant 8,353 $0.00
Neogenomics Inc NEO
Restricted Stock Unit · derivative
2023-08-10 Grant 11,336 $0.00
Rigel Pharmaceuticals Inc RIGL
Stock Option (Right to Buy) · derivative
2023-05-26 Grant 30,000 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2023-05-26 Grant 25,000 $0.00
CytomX Therapeutics Inc CTMX
Common Stock
2022-07-20 Sell 5,602 $1.42 7,955
CytomX Therapeutics Inc CTMX
Common Stock
2022-07-19 Grant 15,000 $0.00
Neogenomics Inc NEO
Stock Option (Right to Buy) · derivative
2022-06-10 Grant 13,882 $0.00
Neogenomics Inc NEO
Common Stock
2022-06-10 Grant 15,556 $0.00
showing 20 of 58 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com